Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.88), $0.17 worse than the analyst estimate of ($0.71).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.